The Usefulness of FDG PET-CT in the Routine Staging of Gastric Cancer: A Retrospective Analysis from the Lead Cancer Center, Pakistan.
Indian J Nucl Med
Department of Surgical Oncology, Shaukat Khanum Hospital and Trust, Peshawar, Pakistan.
Published: January 2025
Background: Accurate staging of tumors is paramount in the management of cancer patients. Current noninvasive modalities like computed tomography (CT) and fluorodeoxyglucose positron emission tomography (FDG PET) scan offer viable approaches to stage the disease; however, the role of FDG PET-CT in gastric cancer remains unclear, in comparison to esophageal and gastroesophageal junction cancers, where they have proven usefulness.
Aim: The primary outcome was to assess the usefulness of FDG PET-CT in staging gastric cancer in our population. The secondary outcome was to compare the positive yield of PET-CT with staging laparoscopy and avidity of FDG PET-CT scan in gastric cancer.
Materials And Methods: In our institution, FDG PET-CT is routinely used in staging gastric cancer, where CT scan does not show metastases. We did a retrospective analysis of data of gastric cancer patients, who were not known to have metastatic disease, who underwent pretreatment staging workup at our institute between January 2018 and December 2022. Tumor and lymph node (LN) avidity and their association with Lauren classification was assessed. Multivariate regression analysis for factors associated with metastases on FDG PET-CT scan with tumor size, nodal status, and node avidity was also assessed. Data were analyzed using SPSS version 26 for descriptive and comparative statistics; multivariate regression analysis was performed to identify factors affecting the diagnosis of metastases on PET-CT. =0.05 was considered statistically significant.
Results: Tumor avidity was shown in 181 (89.16%) patients, and LN avidity in 80 (39.4%) patients. This was independent of the Lauren classification. In addition, previously unidentified metastases were highlighted in 16 (8%) patients. Multivariate regression analysis for factors associated with metastases on FDG PET-CT scan showed a significant association with tumor size ( < 0.001), nodal status ( = 0.005), and node avidity ( = 0.024).
Conclusions: FDG PET-CT scan can identify an additional 8% of previously unidentified metastases, thereby playing a useful role in the staging workup of advanced gastric cancer patients. Approximately 90% of gastric cancers and 40% of LNs were PET avid in our population.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884341 | PMC |
| http://dx.doi.org/10.4103/ijnm.ijnm_69_24 | DOI Listing |
Similar Publications
A Meta-analysis of 68Ga-FAPI PET in Assessment of Ovarian Cancer.
Acad Radiol
March 2025
Department of Nuclear Medicine, Beijing Luhe Hospital, Capital Medical University, Xinhua Road 82, Tong Zhou District, 101199 Beijing, China.
Rationale And Objectives: The objective of this research is to carry out a systematic review and meta-analysis to detect the diagnostic efficacy of 68Ga-FAPI Positron Emission Tomography (PET) Computed Tomography/Magnetic Resonance (CT/MR) in total of the lesions as well as different aspects of metastasis in individuals with ovarian cancers (OC).
Materials And Methods: The PubMed, Embase, Cochrane library, and Web of Science databases were thoroughly searched until the cut-off date of July 23, 2024. The assessment of 68Ga-FAPI PET CT/MR of OC was presented by the included studies.
The patient was a 66-year-old man. He came to our hospital because of abdominal discomfort. A CT scan revealed hypovascular tumors of about 70 mm in the S4/5 and 16 mm in the S6 of the liver.
View Article and Find Full Text PDF[A Case of Duodenal Cancer with a History of Metachronous Multiple Colorectal Cancer Resections Achieving Endoscopic Complete Response following Pembrolizumab Treatment].
Gan To Kagaku Ryoho
February 2025
Dept. of Surgery, Kinki Central Hospital.
A male in his 80s with a history of multiple colorectal cancer resections underwent an upper gastrointestinal endoscopy for anemia investigation, which revealed a non-ampullary duodenal carcinoma. Due to insufficient surgical tolerance for pancreaticoduodenectomy, pharmacotherapy was considered. With informed consent, an MSI test was conducted, showing MSI-high, leading to the initiation of pembrolizumab treatment.
View Article and Find Full Text PDFNovel Clinical PET Tracers in the Pipeline for Melanoma.
Curr Oncol Rep
March 2025
Department of Nuclear Medicine, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Purpose: The aim of this review is to provide an overview of novel clinical PET tracers in the pipeline for melanoma. Secondarily, to provide a head-to-head comparison with the current clinical standard used in clinical practice, [F]FDG, if available.
Recent Findings: [F]FDG PET/CT has become important in the clinical setting for melanoma as it serves many purposes, but lacks other important qualities due its nonspecific nature.
Highlights from the breakout session: diagnosis and classification of vasculitis.
Rheumatology (Oxford)
March 2025
Rheumatology Department, Health New Zealand, Auckland, New Zealand.
The session on 'Diagnosis and Classification of Vasculitis' featured six oral presentations covering various aspects of vasculitis diagnosis and classification. The application of the Ankara criteria for IgA vasculitis in adults was evaluated, finding that while the criteria showed good sensitivity, their specificity was insufficient, suggesting the need for refinement. A clustering approach to classifying ANCA-associated vasculitis (AAV) identified five distinct clusters, which improved prediction of disease outcomes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.